ClinicalTrials.gg
Not yet recruitingNCT07929337Updated Nov 10, 2026

The Effect of Virtual Reality Headset and Hand Massage on Pain, Anxiety, Patient Satisfaction, and Physiological Parameters in Patients Who Have Undergone Abdominal Surgery

An interventional study of Virtual Reality Glasses and Classic Hand Massage in Pain After Surgery, Pain and Anxiety and Anxiety After Surgery, sponsored by Dokuz Eylul University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Dokuz Eylul University · Not applicable, Interventional, and Supportive care

Updated Nov 10, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This randomized controlled trial aims to investigate the effects of using a virtual reality headset and conventional hand massage on pain, anxiety, patient satisfaction, and physiological parameters in patients undergoing abdominal surgery. Participants will be randomly assigned to three groups: the virtual reality group, the conventional hand massage group, and the control group. Pain levels, anxiety levels, satisfaction levels, and physiological parameters will be assessed both before and after the procedure. The study aims to determine whether these non-pharmacological methods improve postoperative pain, anxiety, patient satisfaction, and physiological parameters.

02

Conditions studied

  • Pain After Surgery
  • Pain and Anxiety
  • Anxiety After Surgery
  • Anxiety
  • Abdominal Surgery

Keywords

  • abdominal surgery
  • Virtual Reality
  • Physiological Parameters
  • Pain
  • Anxiety
  • Patient Satisfaction
  • Hand Massage
  • Non-pharmacological Intervention
03

In context

Pain

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

This study's planned enrollment of 66 is close to the median of 66 across 8,493 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Dokuz Eylul University is the lead sponsor of 261 studies on the registry; 35 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Aged 18 and older

      • Who have not previously undergone abdominal surgery
      • Who underwent elective surgery
      • Who had a numerical pain scale score of 3 or higher prior to the procedure
      • Possessing the cognitive ability to tolerate the virtual reality headset application
      • Voluntarily agreeing to participate in the study
      • Patients on the second postoperative day
      • No history of chronic pain (e.g., arthritis)
      • Patients who are alert and oriented enough to communicate (Glasgow Coma Scale 15)
      • Patients with normal vision and hearing
      • Patients suitable for hand massage
      • Patients who are not addicted to alcohol or drugs
      • Patients not taking anxiolytics
      • Patients who can read and understand Turkish

Exclusion criteria

Exclusion Criteria:

    • Those under the age of 18

      • Those with vision or hearing loss
      • Those who are not clinically stable
      • Those who have undergone emergency surgery
      • Those with a known history of epilepsy, vertigo, or limited mobility
      • Those with surgical incisions or wounds in the facial area that prevent them from wearing VR goggles
      • Those using chronic opioids or psychiatric medications
      • Individuals with open wounds, burns, infections, phlebitis, ecchymosis, hematomas, or fractures on their hands
      • Patients with an intravenous catheter in their hand
      • Those who wish to withdraw from the study during the research period
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
66 participants (estimated)

Study arms

  • Experimental
    Virtual Reality Group

    Immediately before the procedure, the fourth researcher will administer the Numerical Pain Scale, the State Anxiety Scale, the Numerical Satisfaction Scale, and the Physiological Parameters Monitoring Form to patients on the second postoperative day at the clinic. Next, the second researcher will fit the patient with a virtual reality headset, and the patient will watch nature-themed videos-such as forest scenes, beach walks, and parks-for 15 minutes. After 15 minutes, the virtual reality session will end. Immediately after the intervention and 30 minutes later, the fourth researcher will have the patients complete the Numerical Pain Scale, State Anxiety Scale, Numerical Satisfaction Scale, and Physiological Parameters Monitoring Form.

    Behavioral: Virtual Reality Glasses

  • Experimental
    Classic Hand Massage Group

    Immediately before the intervention, the fourth researcher will administer the Numerical Pain Scale, State Anxiety Scale, Numerical Satisfaction Scale, and Physiological Parameters Monitoring Form to patients on the second postoperative day at the clinic. Next, the second researcher will perform a classic hand massage for a total of 15 minutes-7.5 minutes on the right hand followed by 7.5 minutes on the left hand. After 15 minutes, the classical hand massage will be discontinued. Immediately after the intervention and 30 minutes later, the fourth researcher will have the patients complete the Numerical Pain Scale, State Anxiety Scale, Numerical Satisfaction Scale, and Physiological Parameters Monitoring Form.

    Behavioral: Classic Hand Massage

  • No intervention
    Control Group

    During the initial patient encounter, the fourth researcher will administer the Numerical Pain Scale, the State Anxiety Scale, the Numerical Satisfaction Scale, and the Physiological Parameters Monitoring Form. In routine clinical practice, care will be continued by the nurse responsible for the patient's care. The second researcher will not perform any additional interventions. At the same time as the group receiving the virtual reality headset application and conventional hand massage, the fourth researcher will have the patients complete the Numerical Pain Scale, State Anxiety Scale, Numerical Satisfaction Scale, and Physiological Parameters Monitoring Form.

Interventions

  • BehavioralVirtual Reality Glasses

    Immediately before the procedure, the fourth researcher will administer the Numerical Pain Scale, the State Anxiety Scale, the Numerical Satisfaction Scale, and the Physiological Parameters Monitoring Form to patients on the second postoperative day at the clinic. Next, the second researcher will fit the patient with a virtual reality headset, and the patient will watch nature-themed videos-such as forest scenes, beach walks, and parks-for 15 minutes. After 15 minutes, the virtual reality session will end. Immediately after the intervention and 30 minutes later, the fourth researcher will have the patients complete the Numerical Pain Scale, State Anxiety Scale, Numerical Satisfaction Scale, and Physiological Parameters Monitoring Form. This distraction technique aims to reduce pain perception and anxiety levels, increase patient satisfaction during the procedure, and improve physiological parameters.

    Also known as: VR Glasses

  • BehavioralClassic Hand Massage

    Immediately before the intervention, the fourth researcher will administer the Numerical Pain Scale, State Anxiety Scale, Numerical Satisfaction Scale, and Physiological Parameters Monitoring Form to patients on the second postoperative day at the clinic. Next, the second researcher will perform a classic hand massage for a total of 15 minutes-7.5 minutes on the right hand followed by 7.5 minutes on the left hand. After 15 minutes, the classical hand massage will be discontinued. Immediately after the intervention and 30 minutes later, the fourth researcher will have the patients complete the Numerical Pain Scale, State Anxiety Scale, Numerical Satisfaction Scale, and Physiological Parameters Monitoring Form. This distraction technique aims to reduce pain perception and anxiety levels, increase patient satisfaction during the procedure, and improve physiological parameters.

    Also known as: Hand Massage

06

What researchers measure

Primary outcomes

  1. Postoperative pain

    Pain intensity will be measured using a Visual Analog Scale (VAS) ranging from 0 (no pain) to 10 (the most severe pain possible). Measurements will be taken three times: on the second day after surgery, immediately before the procedure, immediately after the procedure, and 30 minutes later.

    Time frame: The second day after surgery, immediately before the procedure, immediately after the procedure, and 30 minutes later.

Secondary outcomes

  1. Postoperative anxiety levels

    Anxiety levels will be assessed using the Situational Anxiety Inventory - Short Form (STAIS-S). This scale measures temporary anxiety levels. Scores range from 20 to 80. Measurements will be taken three times: on the second day after surgery; immediately before the procedure; immediately after the procedure; and 30 minutes after the procedure. Higher scores indicate higher (worse) anxiety levels.

    Time frame: The second day after surgery; immediately before the procedure; immediately after the procedure; and 30 minutes after the procedure.

  2. Post-surgery satisfaction levels

    Patient satisfaction will be assessed using a Visual Analog Scale (VAS) ranging from 0 (not at all satisfied) to 10 (extremely satisfied). Measurements will be taken three times: on the second day after surgery; immediately before the procedure; immediately after the procedure; and 30 minutes after the procedure. Higher scores indicate greater satisfaction.

    Time frame: The second day after surgery; immediately before the procedure; immediately after the procedure; and 30 minutes after the procedure.

  3. Systolic Blood Pressure

    Systolic blood pressure will be measured in millimeters of mercury (mmHg). Higher values indicate higher systolic blood pressure.

    Time frame: The second day after surgery; immediately before the procedure; immediately after the procedure; and 30 minutes after the procedure.

  4. Diastolic Blood Pressure

    Diastolic blood pressure will be measured in millimeters of mercury (mmHg). Higher values indicate higher diastolic blood pressure.

    Time frame: The second day after surgery; immediately before the procedure; immediately after the procedure; and 30 minutes after the procedure.

  5. Pulse Rate

    Pulse rate will be measured in beats per minute (beats/min).

    Time frame: The second day after surgery; immediately before the procedure; immediately after the procedure; and 30 minutes after the procedure.

  6. Respiratory Rate

    Respiratory rate will be measured in breaths per minute (breaths/min).

    Time frame: The second day after surgery; immediately before the procedure; immediately after the procedure; and 30 minutes after the procedure.

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Mar 2027, 4 months later.

Of 3,731 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 4 months is below that.

Counting every sponsor, half of 3,830 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 3, 2026
First posted
Nov 10, 2026
StartEst.
Nov 5, 2026
Primary completionEst.
Mar 2027
CompletionEst.
Mar 2027
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07929337
Responsible party
Gizem Göktuna (Assistant Professor, Dokuz Eylul University) — Principal investigator
First posted
Nov 10, 2026
Start date
Nov 5, 2026 (estimated)
Primary completion
Mar 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Nov 10, 2026

Study contacts

Principal Investigator
Contact
gizemgoktuna@gmail.com
+90 232 412 4779

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion